These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7218450)

  • 1. Pathological factors that influence prognosis in stage A prostatic cancer: the influence of extent versus grade.
    Cantrell BB; DeKlerk DP; Eggleston JC; Boitnott JK; Walsh PC
    J Urol; 1981 Apr; 125(4):516-20. PubMed ID: 7218450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended followup.
    Epstein JI; Paull G; Eggleston JC; Walsh PC
    J Urol; 1986 Oct; 136(4):837-9. PubMed ID: 3761442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Operable prostatic carcinoma: correlations among clinical stage, pathological stage, gleason histological score and early disease-free survival.
    Fowler JE; Mills SE
    J Urol; 1985 Jan; 133(1):49-52. PubMed ID: 3964879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4.
    Lau WK; Blute ML; Bostwick DG; Weaver AL; Sebo TJ; Zincke H
    J Urol; 2001 Nov; 166(5):1692-7. PubMed ID: 11586204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pelvic lymph node metastasis from prostatic cancer: influence of tumor grade and stage in 452 consecutive patients.
    Smith JA; Seaman JP; Gleidman JB; Middleton RG
    J Urol; 1983 Aug; 130(2):290-2. PubMed ID: 6876275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation between histologic grading and prognosis of prostatic cancer--comparing the grading system of the Japanese general rules of prostatic cancer with Gleason's grading].
    Hioki T; Sugimura Y; Sakurai M; Hayashi N; Tochigi H; Kawamura J; Yatani R
    Hinyokika Kiyo; 1990 Aug; 36(8):921-6. PubMed ID: 2239593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor volume versus percentage of specimen involved by tumor correlated with progression in stage A prostatic cancer.
    Epstein JI; Oesterling JE; Walsh PC
    J Urol; 1988 May; 139(5):980-4. PubMed ID: 3361676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer in men less than 45 years old: influence of stage, grade and therapy.
    Benson MC; Kaplan SA; Olsson CA
    J Urol; 1987 May; 137(5):888-90. PubMed ID: 3573183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.
    Vesalainen S; Nordling S; Lipponen P; Talja M; Syrjänen K
    Br J Cancer; 1994 Aug; 70(2):309-14. PubMed ID: 8054280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between stage and grade in prostatic adenocarcinoma: a morphometric study.
    Sharkey FE; Dusenbery DM; Moyer JE; Barry JD
    J Urol; 1984 Sep; 132(3):602-5. PubMed ID: 6471204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low Gleason score prostatic adenocarcinomas are no longer viable entities.
    Berney DM
    Histopathology; 2007 May; 50(6):683-90. PubMed ID: 17493232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aid to accurate clinical staging-histopathologic grading in prostatic cancer.
    Thomas R; Lewis RW; Sarma DP; Coker GB; Rao MK; Roberts JA
    J Urol; 1982 Oct; 128(4):726-8. PubMed ID: 7143593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gleason score as predictor of clinicopathologic findings and biochemical (PSA) progression following radical prostatectomy.
    Guimaraes MS; Quintal MM; Meirelles LR; Magna LA; Ferreira U; Billis A
    Int Braz J Urol; 2008; 34(1):23-9. PubMed ID: 18341718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can stage A1 tumor extent be predicted by transurethral resection tumor volume, per cent or grade? A study of 64 stage A1 radical prostatectomies with comparison to prostates removed for stages A2 and B disease.
    Larsen MP; Carter HB; Epstein JI
    J Urol; 1991 Oct; 146(4):1059-63. PubMed ID: 1895422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of volume of nodal metastasis in patients with adenocarcinoma of the prostate.
    Smith JA; Middleton RG
    J Urol; 1985 Apr; 133(4):617-9. PubMed ID: 3920406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The value of cytological grading of prostatic adenocarcinoma. Comparison of the clinical state, the Gleason score and grade in 69 cases].
    Piaton E; Mouriquand J; Berger N; Mouriquand P; Seigneurin D; Devonec M; Perrin P
    J Urol (Paris); 1990; 96(4):211-6. PubMed ID: 2212719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup.
    Epstein JI; Carmichael M; Partin AW; Walsh PC
    J Urol; 1993 Jun; 149(6):1478-81. PubMed ID: 8501792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer: a critical analysis.
    Partin AW; Walsh AC; Pitcock RV; Mohler JL; Epstein JI; Coffey DS
    J Urol; 1989 Nov; 142(5):1254-8. PubMed ID: 2810502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: the influence of prostate specific antigen cancer density.
    Blackwell KL; Bostwick DG; Myers RP; Zincke H; Oesterling JE
    J Urol; 1994 Jun; 151(6):1565-70. PubMed ID: 7514689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term followup of young patients with stage A adenocarcinoma of the prostate.
    Blute ML; Zincke H; Farrow GM
    J Urol; 1986 Oct; 136(4):840-3. PubMed ID: 3761443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.